Overview
Pseudohypoaldosteronism type 1 (PHA1) is characterized by salt-sensitive hypertension, hyperkalemia, and resistance to conventional mineralocorticoid effects, often due to mutations in genes involved in the WNK signaling pathway, including WNK1, WNK4, Kelch-like 3 (KLHL3), and Cullin 3 (CUL3) 1.Diagnosis
Clinical Features: Hyperkalemia, hypertension, thiazide sensitivity, and hyperchloremic metabolic acidosis 2.
Laboratory Tests:
- Elevated serum potassium levels.
- Normal glomerular filtration rate.
- Low plasma renin activity.
- Fractional excretion of potassium may be reduced with sodium chloride loading 2.
Response to Therapy:
- Normal renal potassium excretion with sodium sulfate administration.
- Thiazide diuretics normalize serum potassium, bicarbonate, and blood pressure 2.
Genetic Testing: Identification of mutations in WNK1, WNK4, KLHL3, or CUL3 genes 1.Management
First-Line Treatment:
- Thiazide Diuretics: Effective in normalizing serum potassium, bicarbonate, and blood pressure 2.
Adjunctive Treatments:
- Exogenous Mineralocorticoids: High-dose mineralocorticoids can induce significant natriuresis and kaliuresis in some cases 2.Special Populations
Pregnancy: Specific management guidelines not addressed in provided abstracts.
Pediatrics: Specific management guidelines not addressed in provided abstracts.
Elderly: Specific management guidelines not addressed in provided abstracts.
Comorbidities: Management considerations for comorbidities like chronic kidney disease not detailed in abstracts 12.Key Recommendations
Initiate thiazide diuretics for normalization of hyperkalemia, metabolic acidosis, and hypertension (Evidence: Strong 2).
Consider high-dose exogenous mineralocorticoids to assess for marked natriuresis and kaliuresis in refractory cases (Evidence: Moderate 2).
Genetic testing for mutations in WNK1, WNK4, KLHL3, and CUL3 is recommended for definitive diagnosis (Evidence: Expert opinion 1).References
1 Sohara E, Uchida S. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016. link
2 Travis PS, Cushner HM. Mineralocorticoid-induced kaliuresis in type-II pseudohypoaldosteronism. The American journal of the medical sciences 1986. link